Be a Smart Investor
Monday, December 23, 2019
Eloxx Pharma Up 45% So Far In Dec., What Next?
Shares of Eloxx Pharmaceuticals Inc. (ELOX) are up over 45% so far this month as it awaits the phase II topline data of its lead drug candidate ELX-02 in nephropathic cystinosis.
from RTT - Biotech https://ift.tt/35PrTSb
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment